Randall Stanicky

Pharma

Viatris, or just Mylan with a new name? Analysts say latter

After Viatris laid out its financial targets for the first time as a combined company, analysts questioned its revenue and cash generation plans.
Angus Liu Mar 12, 2021 12:09pm

Pfizer's Ibrance fails early breast cancer trial

May 30, 2020 5:41pm

Allergan preparing to split after years of turmoil: analyst

Jun 19, 2019 10:50am

IRS knocks Perrigo for $873M in unpaid royalties

Apr 30, 2019 12:38pm

When is a ph3 flop a good thing? Just ask Allergan's investors

Mar 7, 2019 11:53am

Could Mylan swing a sale to private equity buyer?

Sep 21, 2018 11:27am